Application 209410

Type
NDA
Sponsor
OSMOTICA PHARM

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OSMOLEX ERAMANTADINE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORALEQ 129MG BASEYesNo
002OSMOLEX ERAMANTADINE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORALEQ 193MG BASEYesNo
003OSMOLEX ERAMANTADINE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORALEQ 258MG BASEYesYes
004OSMOLEX ERAMANTADINE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORALEQ 161MG BASEYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
68025-021Osmolex ERamantadineVertical Pharmaceuticals, LLCNDACurrent
68025-074Osmolex ERamantadineVertical Pharmaceuticals, LLCNDACurrent
68025-074Osmolex ERamantadineVertical Pharmaceuticals, LLCNDACurrent
68025-074Osmolex ERamantadineVertical Pharmaceuticals, LLCNDACurrent
68025-074Osmolex ERamantadineVertical Pharmaceuticals, LLCNDACurrent
68025-075Osmolex ERamantadineVertical Pharmaceuticals,NDACurrent
68025-075Osmolex ERamantadineVertical Pharmaceuticals, LLCNDACurrent
68025-075Osmolex ERamantadineVertical Pharmaceuticals, LLCNDACurrent
68025-075Osmolex ERamantadineVertical Pharmaceuticals, LLCNDACurrent
68025-075Osmolex ERamantadineVertical Pharmaceuticals, LLCNDACurrent
68025-075Osmolex ERamantadineVertical Pharmaceuticals, LLCNDACurrent
68025-076Osmolex ERamantadineVertical Pharmaceuticals, LLCNDACurrent
68025-076Osmolex ERamantadineVertical Pharmaceuticals, LLCNDACurrent
68025-076Osmolex ERamantadineVertical Pharmaceuticals, LLCNDACurrent
68025-076Osmolex ERamantadineVertical Pharmaceuticals, LLCNDACurrent
68025-076Osmolex ERamantadineVertical Pharmaceuticals, LLCNDACurrent
68025-076Osmolex ERamantadineVertical Pharmaceuticals,NDACurrent
68025-077Osmolex ERamantadineVertical Pharmaceuticals,NDACurrent
68025-077Osmolex ERamantadineVertical Pharmaceuticals, LLCNDACurrent
68025-077Osmolex ERamantadineVertical Pharmaceuticals, LLCNDACurrent
68025-077Osmolex ERamantadineVertical Pharmaceuticals, LLCNDACurrent
68025-077Osmolex ERamantadineVertical Pharmaceuticals, LLCNDACurrent
70482-075OSMOLEX ERamantadineAdamas Pharma, LLCNDACurrent
70482-075OSMOLEX ERamantadineAdamas Pharma, LLCNDACurrent
70482-075OSMOLEX ERamantadineAdamas Pharma, LLCNDACurrent
70482-076OSMOLEX ERamantadineAdamas Pharma, LLCNDACurrent
70482-076OSMOLEX ERamantadineAdamas Pharma, LLCNDACurrent
70482-076OSMOLEX ERamantadineAdamas Pharma, LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
82815SUPPL 2025-07-11
82792SUPPL 2025-07-11
57037ORIG2018-12-26
52699ORIG2018-02-23
52687ORIG2018-02-22